Volume 60, Issue 6, Pages (December 2001)

Slides:



Advertisements
Similar presentations
Kamyar Kalantar-Zadeh  Kidney International 
Advertisements

Volume 56, Pages S238-S241 (July 1999)
Volume 57, Issue 5, Pages (May 2000)
Volume 54, Issue 2, Pages (August 1998)
Effect of arginine vasopressin and ANP on intracellular pH and cytosolic free [Ca2+] regulation in MDCK cells  Maria Oliveira-Souza, Margarida Mello-Aires,
Tranilast attenuates connective tissue growth factor-induced extracellular matrix accumulation in renal cells  W. Qi, X. Chen, S. Twigg, T.S. Polhill,
Francesco Locatelli, Lucia Del Vecchio, Simeone Andrulli, Sara Colzani 
Volume 57, Issue 5, Pages (May 2000)
Volume 66, Issue 1, Pages (July 2004)
A.C. McMahon, R.U. Naqvi, M.J. Hurst, A.E.G. Raine, K.T. MacLeod 
Volume 67, Issue 5, Pages (May 2005)
Kamyar Kalantar-Zadeh  Kidney International 
Volume 70, Pages S21-S25 (December 2006)
Abnormalities in lipoprotein metabolism in hemodialysis patients
Comorbidity and confounding in end-stage renal disease
A new era in phosphate binder therapy: What are the options?
Volume 57, Issue 4, Pages (April 2000)
Volume 70, Issue 11, Pages (December 2006)
Joseph W. Eschbach, John W. Adamson  Kidney International 
D. Coyne  Kidney International  Volume 69, Pages S1-S3 (May 2006)
Volume 54, Issue 5, Pages (November 1998)
Volume 55, Issue 3, Pages (March 1999)
Volume 87, Issue 2, Pages (February 2015)
Hemoperitoneum in a woman with acute paraplegia
Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease  S. Bianchi, R. Bigazzi, V.M. Campese 
Correction to "Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate.
Uremia impairs blood dendritic cell function in hemodialysis patients
Acute myocardial infarction in patients with end-stage renal disease
The calcium–phosphorus in guidelines for CKD-MBD
Volume 70, Issue 12, Pages (December 2006)
Blood pressure targets in hemodialysis patients
Volume 72, Issue 12, Pages (December 2007)
Recent experience with high-dose intravenous iron administration
Cardiac arrest and sudden death in dialysis units
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 56, Issue 5, Pages (November 1999)
Volume 67, Issue 5, Pages (May 2005)
AGEs in foods: Do they play a role in uremia?
Volume 79, Issue 7, Pages (April 2011)
Michael W. Steffes, Derek Schmidt, Rebecca Mccrery, John M. Basgen 
Susan K. Fellner, William J. Arendshorst  Kidney International 
Terry Behrend, Steven B. Miller, M.D  Kidney International 
Volume 59, Issue 6, Pages (June 2001)
Effect of asymmetric dimethylarginine on osteoblastic differentiation
Serum cystatin C-immunoglobulin high-molecular-weight complexes in kidney and liver transplant patients  Jesús Hermida, Rafael Romero, J. Carlos Tutor 
Volume 81, Issue 12, Pages (June 2012)
Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study1  Robert N. Foley, Charles A. Herzog, Allan J.
Hemodialysis with high-calcium dialysate impairs cardiac relaxation
The course of the remnant kidney model in mice
Wei-Teing Chen, Horng-Chin Yan, Fu-Chiu Yu  Kidney International 
Phosphate binders on iron basis: A new perspective?
Organ transplantation goes to the movies
Total hip bone mass predicts survival in chronic hemodialysis patients
Volume 63, Issue 2, Pages (February 2003)
Thomas J. Burke, Deepak Malhotra, Joseph I. Shapiro, M.D. 
Volume 80, Issue 10, Pages (November 2011)
Volume 63, Issue 5, Pages (May 2003)
Volume 56, Pages S238-S241 (July 1999)
Volume 60, Issue 6, Pages (December 2001)
Charles A. Herzog  Kidney International 
Miroslaw Smogorzewski, Varuzhan Galfayan, Shaul G. Massry 
Volume 70, Issue 3, Pages (August 2006)
Advisory about gadolinium calls for caution in the treatment of uremic patients with lanthanum carbonate  S. Aime, C. Canavese, P. Stratta  Kidney International 
Volume 53, Issue 4, Pages (April 1998)
Volume 70, Issue 5, Pages (September 2006)
Volume 70, Issue 10, Pages (November 2006)
The International Pediatric Peritonitis Registry: Starting to walk
Volume 61, Issue 4, Pages (April 2002)
Volume 56, Issue 3, Pages (September 1999)
Presentation transcript:

Volume 60, Issue 6, Pages 2367-2376 (December 2001) Effects of uremic serum on isolated cardiac myocyte calcium cycling and contractile function.  Sankaridrug M. Periyasamy, Jie Chen, Derek Cooney, Patricia Carter, Eiad Omran, Jiang Tian, Snigdha Priyadarshi, Alexei Bagrov, Olga Fedorova, Deepak Malhotra, Zijian Xie, Joseph I. Shapiro, M.D.  Kidney International  Volume 60, Issue 6, Pages 2367-2376 (December 2001) DOI: 10.1046/j.1523-1755.2001.00053.x Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 1 Relationship between amount of serum and inhibition of purified NaK-ATPase activity. Symbols are: (●) control patients; (▼) uremic patients. **P < 0.01 vs. control. Kidney International 2001 60, 2367-2376DOI: (10.1046/j.1523-1755.2001.00053.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 2 Relationships between the concentration of ouabain (A) and uremic serum extract (B) and inhibition of 86Rb uptake in LLCPK-1 (●) and NRK (▼) cells. Kidney International 2001 60, 2367-2376DOI: (10.1046/j.1523-1755.2001.00053.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 3 Representative responses of cellular contraction and Indo-1 fluorescence to addition of uremic extract 1.5%. Effects of calibration with ionomycin and EGTA also are shown. Kidney International 2001 60, 2367-2376DOI: (10.1046/j.1523-1755.2001.00053.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 4 Representative cell length (A) and cytosolic calcium (B) measurements obtained from cardiac myocytes exposed to deproteinized normal and uremic serum extracts (3.75%) during field stimulation at 0.5Hz. Kidney International 2001 60, 2367-2376DOI: (10.1046/j.1523-1755.2001.00053.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 5 Effect of Fab fragment directed against digitalis (D) on the uremic extract pooled from 4 of the 5 patients (UE, 10%) inhibition of 86Rb uptake in LLCPK-1 cells. Each data point was derived from N = 3 experiments. D is Fab fragment alone (10, 20 and 40 μL data pooled). Final reaction volume was approximately 1mL. *P < 0.05 and **P < 0.01 vs. UE alone. D alone not compared with UE alone. Kidney International 2001 60, 2367-2376DOI: (10.1046/j.1523-1755.2001.00053.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 6 Effect of Fab fragment (D) on uremic extract (UE 3.5%) effects on myocyte contraction, relaxation and calcium cycling. Data are presented as percent change from baseline after 5 minutes following addition of UE alone or UE mixed with D. Each data point was obtained from N = 4 replicants. Symbols are: (□) fractional shortening; () diastolic [Ca]; () systolic [Ca]; () τ edge; () τ calcium. *P < 0.05 and **P < 0.01 vs UE alone. Kidney International 2001 60, 2367-2376DOI: (10.1046/j.1523-1755.2001.00053.x) Copyright © 2001 International Society of Nephrology Terms and Conditions